Pediatrix Medical Group, Inc.
MD Healthcare Medical Care Facilities
Pediatrix Medical Group, Inc.’s revenue for fiscal 2025 (year ended December 2025) was $1.9 billion, down 4.92% from fiscal 2024. In the quarter to June 2026, revenue grew 4.04%, EPS grew 6.52%, free cash flow fell 6.56% and total debt fell 3.84%, each against the same quarter a year earlier.
Follow MD
Pediatrix Medical Group, Inc. (MD) EV/Sales
As of 16 October 2026, Pediatrix Medical Group, Inc. (MD) trades at a EV/Sales of 1.2×. Over the past ten years it has ranged from 0.5× (July 2024) to 4.1× (December 2019); the current reading is higher than 37% of that period. That is below the Medical Care Facilities industry median of 1.3× and below the Healthcare sector median of 3.4×.
EV/Sales, daily
Embed this chart
Annual newest first
| Period | EV/Sales | Change |
|---|---|---|
| FY2025 | 1.0× | 46.36% |
| FY2024 | 0.7× | 10.07% |
| FY2023 | 0.6× | (32.69%) |
| FY2022 | 0.9× | (38.21%) |
| FY2021 | 1.5× | (1.54%) |
| FY2020 | 1.5× | (10.10%) |
| FY2019 | 1.7× | (41.42%) |
| FY2018 | 2.9× | 35.60% |
| FY2017 | 2.1× | (14.49%) |
| FY2016 | 2.5× | (13.28%) |
Quarterly newest first
| Period | EV/Sales | Change |
|---|---|---|
| Jun 2026 | 1.1× | 9.00% |
| Mar 2026 | 1.0× | 4.08% |
| Dec 2025 | 1.0× | 22.35% |
| Sep 2025 | 0.8× | 6.46% |
| 42 more quarters | Free account |
Against its own ten years
EV/Sales against peers
| Company | EV/Sales |
|---|---|
| ARDT Ardent Health, Inc. compare | 0.3× |
| ASTH Astrana Health, Inc. compare | 0.6× |
| MD Pediatrix Medical Group, Inc. | 1.2× |
| ADUS Addus HomeCare Corporation compare | 1.4× |
| ACHC Acadia Healthcare Company, Inc. compare | 1.5× |
| AVAH Aveanna Healthcare Holdings Inc. compare | 1.6× |
| SGRY Surgery Partners, Inc. compare | 1.6× |
| GRDN Guardian Pharmacy Services, Inc. compare | 1.7× |
| BKD Brookdale Senior Living Inc. compare | 2.1× |
| Medical Care Facilities industry median | 1.3× |
| Healthcare sector median | 3.4× |
| Market median | 2.1× |
What EV/Sales is
EV/Sales tells an investor how the value of a whole company, counting its debt and cash, compares with the sales it brings in.
((Stock Price × Shares (Basic, Weighted) (latest quarter)) + (Long Term Debt (Total) (latest quarter) + Current Part of Debt (latest quarter)) − Cash & Short Term Investments (latest quarter)) ÷ Revenue (TTM)